Celebrating 20 years
Brain imaging abnormalities and outcome after acute ischaemic stroke: the ENCHANTED trial
Building back better after COVID-19: The research agenda
The wider benefits of SGLT2 inhibitors
A number of cross-sectional surveys into vascular risk assessment and management in Australian primary care settings were undertaken by staff at the Institute, which has resulted in changes made to the 2009 Absolute Risk Assessment Guidelines.